Despite having lower respiratory muscle strength, people with pulmonary arterial hypertension (PAH) can still use dry powder inhalers that…
Articles by Joana Carvalho, PhD
Top-line data from a Phase 1 clinical trial has found that treprostinil palmitil inhalation powder (TPIP) — a dry powder…
The U.S. Food and Drug Administration (FDA) has approved Alembic Pharmaceuticals’ injectable formulation of treprostinil, a generic version…
United Therapeutics is planning to ask the U.S. Food and Drug Administration (FDA) for an accelerated review of Tyvaso DPI,…
The Pulmonary Hypertension Association U.K. (PHA UK), a charity organization dedicated to supporting those with pulmonary hypertension (PH),…
The U.S. Food and Drug Administration (FDA) determined that additional data is required to support the potential approval of…
Liquidia Technologies, the developer of an inhaled formulation of treprostinil…
Tenax Therapeutics has acquired developmental and commercial rights for North America to an oral formulation of levosimendan, a…
An imbalance in the composition of bacteria living in the gut, a phenomenon known as dysbiosis, may play a…
Moderna has entered a collaboration agreement with Chiesi Farmaceutici to develop new messenger RNA-based therapies for pulmonary…
Despite current targeted therapies, premature babies with bronchopulmonary dysplasia or BPD — a disease in which the lungs become…
Robot-assisted pulmonary artery denervation (PADN) — a minimally invasive surgical procedure that destroys some of the nerves innervating the…